News-Medical.Net on MSN4d
Firefighting chemicals leave brain cancer-linked mutations, study showsFirefighters show higher rates of glioma-linked SBS42 mutational signatures associated with haloalkane exposure, suggesting ...
Along the way, Jackson, Pardoll and colleagues found that tumors with a mutation in the IDH1 gene, which are less aggressive, had almost no MDSCs and far fewer cancer stem cells. This led them to ...
Along the way, Jackson, Pardoll and colleagues found that tumors with a mutation in the IDH1 gene, which are less aggressive, had almost no MDSCs and far fewer cancer stem cells. This led them to ...
SurvivorNet on MSN6mon
Breakthrough Hope: A Revolutionary Advance in Treating Brain Cancer Called Glioma– The Drug Vorasidenib Represents The First Progress in 20 YearsThe medication is a dual inhibitor of the IDH mutation (IDH1 and IDH2 ... From this perspective, the discovery of a mutation ...
https://www.uksh.de/Das+UKSH/Presse/Presseinformationen/2025/Personalisierte+The... https://tu-dresden.de/med/mf/die-fakultaet/newsuebersicht/personalisierte-therap ...
In an earlier study, patients with biomarker-positive high-grade glioma lived longer after treatment with DB107 than biomarker-negative patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback